Welcome back, everyone. Nice to see you again after a much-needed break. Hope your own time off was pleasant. Now, of course, the routine of meetings and deadlines has returned. To cope, we are brewing a mandatory cup of stimulation - our flavor today is Wild Mountain Blueberry. Please join us as we catch up with the recent news of the world. And so, here are some tidbits to help your day get started. Stay in touch...
FDA Staff Raises Safety Concern With Merck Hepatitis C Drug (Reuters)
Vertex Hopes FDA Panel Will OK Its Hep C Treatment (Boston Globe)
AstraZeneca To Demolish R&D Facility (Delaware Online)
Eisai Aricept Patch For Alzheimer's Fails To Win FDA Approval (Bloomberg News)
Sun Pharma To Sell Merck Diabetes Drugs In India (Reuters)
Dr. Reddy's To Sell Pfizer Antidepressant As Of June (Bloomberg News)
Ireland Indemnified Glaxo Over Swine Flu Vaccine (Irish Independent)
Pfizer Stops Making Canine Tick Med Over Side Effects (Veterinary Practice News)
Michigan Supplier Fined $8M Over Oxycodone Prescriptions (Detroit Free Press)
Doctor Hopes To Give Viagra Stiff Competition (Belfast Telegraph)
Pfizer Clarifies Deaths In RA Drug Trial (TheStreet)
Warner-Chilcott To Axe 500 Jobs In Europe (InPharma Technologist)
EDITOR'S NOTE: Check this post for additional headlines each morning
Coffee pix thx to chichcacha flickr creative commons
1 Comment
Sorry to "stiff" Professor Dinsmore, but Pfizer already inroduced Viagra Chewies in Mexico last month. Sort of like Flintstones for adults.